Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00848133 · ClinicalTrials.gov registry record · Phase 4

A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty

A Phase 4 study of Total Knee Arthroplasty, sponsored by Sinai Hospital of Baltimore.

Completed
Registry status
Phase 4
Development phase
51
Enrollment target
1
Study location

NCT00848133: Completed Phase 4 study of Total Knee Arthroplasty, sponsored by Sinai Hospital of Baltimore.

NCT00848133 is a Phase 4 study of Total Knee Arthroplasty that has completed, run by Sinai Hospital of Baltimore. The registered enrollment target is 51 participants, below the 293-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00848133, a Phase 4 study of Total Knee Arthroplasty, has completed, sponsored by Sinai Hospital of Baltimore.

COMPLETED
Registry status
Phase 4
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to compare the early clinical outcomes of minimally invasive bilateral subvastus and midvastus approaches for total knee arthroplasty.

Conditions Studied

Interventions

  • PROCEDURE mini-midvastus surgical approach for total knee arthroplasty
  • PROCEDURE mini-subvastus surgical approach for total knee arthroplasty

Study Locations (1)

Illinois

  • Bonutti Clinic - Effingham

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2004-07
Est. Completion 2009-02
Phase Phase 4
Sinai Hospital of Baltimore

1 total trials

What the finished NCT00848133 record still lists

NCT00848133 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 293-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which mini-midvastus surgical approach for total knee arthroplasty is the first listed.

NCT00848133 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00848133 about?

NCT00848133 is a clinical study titled "A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty". The purpose of this study was to compare the early clinical outcomes of minimally invasive bilateral subvastus and midvastus approaches for total knee arthroplasty.

What is the current status of trial NCT00848133?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2004-07. Estimated completion is 2009-02.

What conditions does trial NCT00848133 study?

This clinical trial studies the following conditions: Total Knee Arthroplasty.

What interventions are being tested in trial NCT00848133?

The interventions under investigation include: mini-midvastus surgical approach for total knee arthroplasty (PROCEDURE), mini-subvastus surgical approach for total knee arthroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT00848133?

This trial is sponsored by Sinai Hospital of Baltimore, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00848133 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Knee Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00848133's enrollment target sits among peer trials

51 25th of 29 higher than 4 of 29 other Total Knee Arthroplasty trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00848133, the US trial registry maintained by the National Library of Medicine. NCT00848133 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.